Seatown Holdings Cut Its Alexion Pharmaceuticals (ALXN) Holding; Johnson Investment Counsel Has Trimmed Its Honeywell International (HON) Position

Honeywell International Inc. (NYSE:HON) Logo

Seatown Holdings decreased Alexion Pharmaceuticals Inc (ALXN) stake by 46.4% reported in 2018Q1 SEC filing. Seatown Holdings sold 51,500 shares as Alexion Pharmaceuticals Inc (ALXN)’s stock declined 2.96%. The Seatown Holdings holds 59,500 shares with $6.63M value, down from 111,000 last quarter. Alexion Pharmaceuticals Inc now has $27.74B valuation. The stock increased 2.47% or $3.005 during the last trading session, reaching $124.665. About 351,800 shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has risen 19.53% since June 29, 2017 and is uptrending. It has outperformed by 6.96% the S&P500. Some Historical ALXN News: 26/04/2018 – ALEXION PHARMACEUTICALS INC – PHASE 3 SWITCH STUDY ALSO DEMONSTRATED NON-INFERIORITY ON ALL FOUR KEY SECONDARY ENDPOINTS; 11/04/2018 – Alexion Intends to Finance the Acquisition of Wilson Through Cash on Hand; 24/04/2018 – ALEXION: OFFER DOCUMENT ON ALEXION’S RECOMMENDED PUBLIC CASH; 15/03/2018 – ALEXION PHARMACEUTICALS – ALXN1210 ALSO ACHIEVED NON-INFERIORITY TO SOLIRIS ON CO-PRIMARY ENDPOINTS OF LACTATE DEHYDROGENASE NORMALIZATION; 11/04/2018 – Alexion Offers SEK232 in Cash for Each Wilson Therapeutics Share; 25/05/2018 – Alexion: Wilson Therapeutics Holders Accept Offer; 15/03/2018 – Alexion’s rare blood disorder drug succeeds in late-stage study; 26/04/2018 – Alexion Pharmaceuticals 1Q EPS $1.11; 25/05/2018 – Alexion Offer for Wilson Therapeutics Accepted; 15/03/2018 – ALEXION PHARMACEUTICALS INC – SAFETY PROFILE OF ALXN1210 CONSISTENT WITH THAT SEEN FOR SOLIRIS

Johnson Investment Counsel Inc decreased Honeywell International Inc. (HON) stake by 13.31% reported in 2018Q1 SEC filing. Johnson Investment Counsel Inc sold 4,774 shares as Honeywell International Inc. (HON)’s stock declined 3.73%. The Johnson Investment Counsel Inc holds 31,087 shares with $4.49M value, down from 35,861 last quarter. Honeywell International Inc. now has $108.23 billion valuation. The stock increased 1.23% or $1.765 during the last trading session, reaching $144.895. About 677,891 shares traded. Honeywell International Inc. (NYSE:HON) has risen 12.64% since June 29, 2017 and is uptrending. It has outperformed by 0.07% the S&P500. Some Historical HON News: 12/03/2018 – Honeywell, other US companies look to benefit from China’s gigantic ‘Belt and Road’ initiative; 30/05/2018 – Romania’s OMV Petrom to Use Honeywell Connected Plant to Improve Reliability of Refinery Operations; 20/04/2018 – HONEYWELL SAYS IT HAS PUT IN PLACE “AGGRESSIVE MITIGATION STRATEGIES” THAT LARGELY OFFSET ANY IMPACT TO CO – CONF CALL; 23/05/2018 – Cureton Midstream To Use Honeywell Connected Plant To Improve Reliability Of Gas Processing; 04/05/2018 – Honeywell: Planned Spinoff of Honeywell Homes Is Expected to Be Completed by the End of 2018; 20/04/2018 – Honeywell Raises Outlook as Equipment Demand Rises; 12/03/2018 – Honeywell Helps Refiners Meet Euro V Standards With New Catalyst; 08/05/2018 – Algeria’s Sonatrach To Produce Cleaner-Burning Transportation Fuels Using Honeywell Technologies; 23/05/2018 – Honeywell Introduces New Mobile Solutions To Help Retailers Improve Store Operations And Deliver A Seamless Shopping Experience; 14/05/2018 – HONEYWELL AUTOMATION INDIA LTD HONE.NS – RECOMMENDED DIVIDEND OF 32 RUPEES PER SHARE

Investors sentiment decreased to 0.91 in Q1 2018. Its down 0.20, from 1.11 in 2017Q4. It dropped, as 64 investors sold HON shares while 536 reduced holdings. 110 funds opened positions while 434 raised stakes. 518.09 million shares or 2.49% less from 531.30 million shares in 2017Q4 were reported. Ancora Advsr Lc, Us-based fund reported 94,720 shares. Cahill Finance Advsrs Inc holds 0.4% of its portfolio in Honeywell International Inc. (NYSE:HON) for 5,776 shares. Teacher Retirement Of Texas has 443,726 shares for 0.43% of their portfolio. Pinebridge Invs Ltd Partnership stated it has 160,585 shares or 0.55% of all its holdings. Abner Herrman & Brock Lc stated it has 2.08% of its portfolio in Honeywell International Inc. (NYSE:HON). Evermay Wealth Mngmt Llc, Virginia-based fund reported 1,570 shares. Caisse De Depot Et Placement Du Quebec invested 0.06% of its portfolio in Honeywell International Inc. (NYSE:HON). First Bancshares & Of Newtown owns 1.29% invested in Honeywell International Inc. (NYSE:HON) for 32,477 shares. Sumitomo Mitsui Asset Mgmt Com owns 50,685 shares. Oppenheimer And owns 153,404 shares for 0.57% of their portfolio. Kings Point Capital Mngmt has invested 2.36% in Honeywell International Inc. (NYSE:HON). Partnervest Advisory Serv Llc has 2,356 shares. Coastline Trust has invested 0.45% in Honeywell International Inc. (NYSE:HON). 21,060 were reported by Sns Group Incorporated Ltd Liability Com. Pub Employees Retirement Systems Of Ohio holds 0.39% in Honeywell International Inc. (NYSE:HON) or 517,636 shares.

Among 9 analysts covering Honeywell International (NYSE:HON), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. Honeywell International had 16 analyst reports since January 3, 2018 according to SRatingsIntel. Stifel Nicolaus maintained it with “Buy” rating and $15700 target in Tuesday, April 3 report. The firm earned “Hold” rating on Wednesday, January 3 by RBC Capital Markets. The firm has “Buy” rating given on Friday, January 26 by Robert W. Baird. The company was maintained on Friday, January 19 by Credit Suisse. The stock of Honeywell International Inc. (NYSE:HON) earned “Overweight” rating by Barclays Capital on Monday, April 23. The firm has “Buy” rating by Robert W. Baird given on Tuesday, February 20. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, February 15. The stock of Honeywell International Inc. (NYSE:HON) earned “Buy” rating by Stifel Nicolaus on Monday, January 29. The company was maintained on Monday, April 23 by Stifel Nicolaus. The firm has “Buy” rating given on Friday, January 19 by Stifel Nicolaus.

Johnson Investment Counsel Inc increased Schwab Us Broad Market Etf (SCHB) stake by 9,262 shares to 23,102 valued at $1.47 million in 2018Q1. It also upped Procter & Gamble Company (NYSE:PG) stake by 234,355 shares and now owns 2.56M shares. Vanguard Intermediate (VCIT) was raised too.

More recent Honeywell International Inc. (NYSE:HON) news were published by: Seekingalpha.com which released: “Honeywell: A Dividend Stock With Low Upside” on June 18, 2018. Also Streetinsider.com published the news titled: “Wolfe Research Starts Honeywell International (HON) at Outperform” on June 28, 2018. 247Wallst.com‘s news article titled: “Top Analyst Upgrades and Downgrades: AT&T, Abbott Labs, Honeywell, Tiffany, Zimmer Biomet and More” with publication date: June 27, 2018 was also an interesting one.

Since February 14, 2018, it had 0 insider purchases, and 4 selling transactions for $18.59 million activity. 2,868 shares were sold by PARDO JAIME CHICO /FA, worth $448,440. Another trade for 114,489 shares valued at $17.20 million was sold by Mahoney Timothy O.. Shares for $426,291 were sold by Deily Linnet F on Wednesday, February 14.

Analysts await Honeywell International Inc. (NYSE:HON) to report earnings on July, 20. They expect $1.99 EPS, up 10.56% or $0.19 from last year’s $1.8 per share. HON’s profit will be $1.49B for 18.20 P/E if the $1.99 EPS becomes a reality. After $1.95 actual EPS reported by Honeywell International Inc. for the previous quarter, Wall Street now forecasts 2.05% EPS growth.

Seatown Holdings increased Goodyear Tire & Rubr Co (NASDAQ:GT) stake by 323,058 shares to 842,926 valued at $22.41 million in 2018Q1. It also upped Schwab Charles Corp New (NYSE:SCHW) stake by 9,800 shares and now owns 338,316 shares. Allergan Plc was raised too.

Since January 2, 2018, it had 1 insider purchase, and 16 sales for $4.25 million activity. ORLOFF JOHN J sold 2,115 shares worth $250,691. Shares for $556,776 were sold by O’Neill Julie on Tuesday, February 6. Franchini Indrani Lall had sold 1,459 shares worth $169,696. HANTSON LUDWIG had sold 13,245 shares worth $1.54M on Tuesday, February 6. $147,865 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was sold by Moriarty John B. Shares for $194,982 were sold by Goff Brian. On Monday, April 30 the insider COUGHLIN CHRISTOPHER J bought $1.21 million.

Investors sentiment decreased to 1 in Q1 2018. Its down 0.03, from 1.03 in 2017Q4. It turned negative, as 43 investors sold ALXN shares while 184 reduced holdings. 60 funds opened positions while 167 raised stakes. 200.94 million shares or 1.68% less from 204.38 million shares in 2017Q4 were reported. Nelson Van Denburg Campbell Wealth Group Inc Lc has 0% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 7 shares. Meeder Asset Mngmt has invested 0.08% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Mckinley Carter Wealth owns 2,300 shares for 0.08% of their portfolio. Moreover, Architects has 0.08% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Da Davidson Co reported 1,975 shares or 0% of all its holdings. Brown Advisory invested in 0% or 4,602 shares. Ingalls & Snyder Limited reported 6,999 shares. Jpmorgan Chase And has invested 0.02% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Comerica Securities invested in 0.06% or 4,260 shares. Prudential Fincl invested 0.05% of its portfolio in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Natl Bank Of Nova Scotia owns 28,217 shares or 0.02% of their US portfolio. Amp Capital Invsts Ltd owns 83,528 shares. Kepos Capital Ltd Partnership has invested 0.18% in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Dnb Asset Mgmt As has 25,108 shares. Moreover, Gateway Invest Advisers Llc has 0.14% invested in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) for 141,829 shares.

Among 14 analysts covering Alexion Pharmaceuticals (NASDAQ:ALXN), 13 have Buy rating, 0 Sell and 1 Hold. Therefore 93% are positive. Alexion Pharmaceuticals had 23 analyst reports since January 4, 2018 according to SRatingsIntel. On Friday, February 9 the stock rating was maintained by Deutsche Bank with “Buy”. The stock has “Outperform” rating by Raymond James on Thursday, January 4. The firm earned “Buy” rating on Monday, April 23 by Raymond James. On Thursday, February 8 the stock rating was maintained by BMO Capital Markets with “Buy”. The company was maintained on Thursday, February 8 by Stifel Nicolaus. Jefferies maintained the stock with “Hold” rating in Thursday, February 8 report. The firm earned “Outperform” rating on Friday, March 16 by Credit Suisse. The rating was maintained by Morgan Stanley with “Overweight” on Friday, February 9. The firm has “Buy” rating by Robert W. Baird given on Thursday, March 15. Piper Jaffray maintained the stock with “Buy” rating in Thursday, February 8 report.

More notable recent Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) news were published by: Bizjournals.com which released: “Take a look at the Seaport’s newest office” on June 29, 2018, also Streetinsider.com with their article: “Alexion Pharma (ALXN) Submits Application for Approval of ALXN1210 as Treatment for PNH in European Union” published on June 28, 2018, Businesswire.com published: “Alexion to Report Second Quarter 2018 Results on Thursday, July 26, 2018” on June 28, 2018. More interesting news about Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) were released by: Bizjournals.com and their article: “Future home of PTC, Alexion could sell for $450M” published on June 20, 2018 as well as 247Wallst.com‘s news article titled: “Short Sellers Run for Cover From Major Biotechs” with publication date: June 27, 2018.

Analysts await Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) to report earnings on July, 26. They expect $1.47 earnings per share, up 12.21% or $0.16 from last year’s $1.31 per share. ALXN’s profit will be $327.08M for 21.20 P/E if the $1.47 EPS becomes a reality. After $1.53 actual earnings per share reported by Alexion Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -3.92% negative EPS growth.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) Institutional Positions Chart